David Bejker
Director/Board Member at ABLIVA AB
Network origin in David Bejker first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
21
| Public Company | Pharmaceuticals: Major | 21 |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden.
6
| Subsidiary | Miscellaneous Commercial Services | 6 |
Amylonix AB
 Amylonix AB Pharmaceuticals: MajorHealth Technology Amylonix AB develops pharmaceuticals focused on the neurodegenerative area. Amylonix AB is based in Johanneshov, Sweden. It was founded in 2018 by Karin Marianne Hansson, who has been the CEO since 2018.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Disruptive Pharma Holding AB
1
| Subsidiary | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to David Bejker via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Lund | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| Royal Institute of Technology | College/University | Graduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Graduate Degree | |
| Stockholm School of Economics | College/University | Graduate Degree Graduate Degree Masters Business Admin Masters Business Admin | |
Atlas Antibodies AB
 Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Biotechnology | Founder Director/Board Member Chief Executive Officer Director/Board Member | |
Maas Biolab LLC
 Maas Biolab LLC Pharmaceuticals: MajorHealth Technology Maas Biolab LLC manufactures vaccines for chronic neurodegenerative diseases such as amyotrophic lateral sclerosis, Parkinson's, and Alzheimer's. The American company was founded by Marcus Keep and Eskil Elmér, with Marcus Keep serving as CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Founder | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| University of Stockholm | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact | |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
Targovax Oy
 Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Oncopeptides Incentive AB | Corporate Officer/Principal Director/Board Member | ||
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
| Stayble AB | Director/Board Member Director/Board Member | ||
| STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
KTH Holding AB
 KTH Holding AB Investment ManagersFinance KTH Holding AB (KTH Holding) is a venture capital subsidiary of Royal Institute of Technology founded in 1994. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Director/Board Member Private Equity Investor | |
| BIOTAGE AB | Medical Specialties | Founder Chief Executive Officer | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Antibodies Incentive AB | Chairman Corporate Officer/Principal | ||
Scandibio Therapeutics AB
 Scandibio Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Scandibio Therapeutics AB is a Swedish company that specializes in omics data integration, including transcriptomics, proteomics, metabolomics, and metagenomics, using biological networks. Scandibio Therapeutics is based in Stockholm, SE, and was founded by Karin Marianne Hansson, who has been the CEO since incorporation. The private company also study host-microbiome interactions to understand whole body metabolism in health and diseases. The company employs the latest technology and science, such as genome-scale metabolic models, protein-protein interaction networks, transcriptional regulatory networks, signaling networks, metabolic co-factors, host metabolism, microbiome analysis, and clinical studies. | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Consultant / Advisor Private Equity Investor | |
OBN (UK) Ltd.
 OBN (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services OBN (UK) Ltd. is a non-profit organization, which focuses on supporting and bringing together the UK’s life sciences companies, corporate partners and investors. The company is headquartered in Abingdon, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| INTERVACC AB | Biotechnology | Director/Board Member Director/Board Member | |
| CANTARGIA AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
| AEROCRINE AB | Electronic Equipment/Instruments | Founder Director/Board Member | |
| AROCELL AB | Medical Specialties | Chairman Founder | |
Cellectricon AB
 Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Miscellaneous Commercial Services | Founder Director/Board Member | |
SAGA Diagnostics AB
 SAGA Diagnostics AB Medical/Nursing ServicesHealth Services Saga Diagnostics AB operates as a personalized cancer medicine and disease monitoring company. The firm's services include Gene Mutation analysis, circulating tumor DNA and Chromosome analysis. The company was founded by Lao Saal and Anthony George in 2016 and is headquartered in Lund, Sweden. | Medical/Nursing Services | Chairman Corporate Officer/Principal | |
Investor Growth Capital AB
 Investor Growth Capital AB Investment ManagersFinance Investor Growth Capital AB (IGC) is a venture capital subsidiary of Investor AB founded in 1968. The firm is headquartered Stockholm, Sweden. | Investment Managers | Private Equity Investor President | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The University of Edinburgh | College/University | Doctorate Degree Undergraduate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
| CELLAVISION AB | Medical Specialties | Director/Board Member Director of Finance/CFO | |
| University of Copenhagen | College/University | Director/Board Member Undergraduate Degree | |
| University of Uppsala | College/University | Undergraduate Degree Graduate Degree | |
| MEDIVIR AB | Pharmaceuticals: Major | Chairman Chairman | |
| University of Oslo | College/University | Director/Board Member Undergraduate Degree | |
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Medical Specialties | Chief Executive Officer Director/Board Member | |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Medical Specialties | Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Director/Board Member | |
Goldstein Schechter Koch PA
 Goldstein Schechter Koch PA Miscellaneous Commercial ServicesCommercial Services Goldstein Schechter Koch PA provides accounting services. It offers inbound foreign tax, business valuations, litigation support, tax compliance, financial concierge, consulting, and wealth advisory services to a client base of public and private middle market businesses, nonprofits, and high net worth individuals. The company was founded in 1949 and is headquartered in Coral Gables, FL. | Miscellaneous Commercial Services | Director/Board Member | |
Bilcare, Inc.
 Bilcare, Inc. Medical SpecialtiesHealth Technology Bilcare, Inc. supplies dental equipment. The firm offers design, formulation development, manufacturing, packaging, labeling, storage and distribution of clinical supplies for the dental industry. Its other services include pre-formulation, research and development, analytical and stability studies, controlled temperature returns, destructions accountability and consulting services. The company is headquartered in Phoenixville, PA. | Medical Specialties | Director/Board Member | |
| Immodulate Pharma AB | Director/Board Member | ||
Targinta AB
 Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Biotechnology | Chairman | |
| Osi, Inc. | Director/Board Member |
Statistics
International
| Sweden | 38 |
| United States | 7 |
| United Kingdom | 5 |
| Finland | 2 |
| Denmark | 2 |
Sectoral
| Health Technology | 25 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Finance | 5 |
| Electronic Technology | 2 |
Operational
| Director/Board Member | 295 |
| Chairman | 77 |
| Corporate Officer/Principal | 68 |
| Independent Dir/Board Member | 59 |
| Chief Executive Officer | 53 |
Most connected contacts
- Stock Market
- Insiders
- David Bejker
- Company connections
